publication venue for
- Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience.. 16:-. 2026
- Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.. 15:-. 2025
- CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.. 15:-. 2025
- Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.. 14:-. 2024
- Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma.. 13:-. 2023
- Global disparities in patients with multiple myeloma: a rapid evidence assessment.. 13:-. 2023
- The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.. 13:-. 2023
- Racial differences as predictors of outcomes in young patients with multiple myeloma.. 12:-. 2022
- Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes.. 11:-. 2021
- Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.. 11:-. 2021
- Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C.. 6:-. 2016
- Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma.. 5:-. 2015